Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Clin Invest ; 126(11): 4361-4371, 2016 11 01.
Article in English | MEDLINE | ID: mdl-27760050

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) is a risk factor for type 2 diabetes (T2D), but whether NAFLD plays a causal role in the pathogenesis of T2D is uncertain. One proposed mechanism linking NAFLD to hepatic insulin resistance involves diacylglycerol-mediated (DAG-mediated) activation of protein kinase C-ε (PKCε) and the consequent inhibition of insulin receptor (INSR) kinase activity. However, the molecular mechanism underlying PKCε inhibition of INSR kinase activity is unknown. Here, we used mass spectrometry to identify the phosphorylation site Thr1160 as a PKCε substrate in the functionally critical INSR kinase activation loop. We hypothesized that Thr1160 phosphorylation impairs INSR kinase activity by destabilizing the active configuration of the INSR kinase, and our results confirmed this prediction by demonstrating severely impaired INSR kinase activity in phosphomimetic T1160E mutants. Conversely, the INSR T1160A mutant was not inhibited by PKCε in vitro. Furthermore, mice with a threonine-to-alanine mutation at the homologous residue Thr1150 (InsrT1150A mice) were protected from high fat diet-induced hepatic insulin resistance. InsrT1150A mice also displayed increased insulin signaling, suppression of hepatic glucose production, and increased hepatic glycogen synthesis compared with WT controls during hyperinsulinemic clamp studies. These data reveal a critical pathophysiological role for INSR Thr1160 phosphorylation and provide further mechanistic links between PKCε and INSR in mediating NAFLD-induced hepatic insulin resistance.


Subject(s)
Dietary Fats/adverse effects , Insulin Resistance , Liver/metabolism , Non-alcoholic Fatty Liver Disease/metabolism , Receptor, Insulin/metabolism , Signal Transduction/drug effects , Amino Acid Substitution , Animals , Diabetes Mellitus, Type 2/genetics , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/pathology , Dietary Fats/pharmacology , Glycogen/biosynthesis , Glycogen/genetics , Liver/pathology , Mice , Mice, Mutant Strains , Mutation, Missense , Non-alcoholic Fatty Liver Disease/chemically induced , Non-alcoholic Fatty Liver Disease/genetics , Phosphorylation , Protein Kinase C-epsilon/genetics , Protein Kinase C-epsilon/metabolism , Receptor, Insulin/genetics
2.
Ann Neurol ; 55(2): 286-90, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14755734

ABSTRACT

Stiff-Man syndrome (SMS) is a rare disease of the central nervous system characterized by chronic muscle rigidity and autoimmunity directed against synaptic antigens. In a subset of patients, generally positive for antiamphiphysin autoantibodies, SMS has an autoimmune paraneoplastic origin. Amphiphysin isoforms are expressed at high levels in brain and skeletal muscle and often are overexpressed in breast cancer. We report here the occurrence of rhabdomyolysis in a patient with SMS, breast cancer, and antibodies that recognize both brain and muscle amphiphysin isoforms. Immunotherapy induced a remission of both rhabdomyolysis and SMS symptoms. Autoimmune rhabdomyolysis may represent a paraneoplastic complication of cancer patients with amphiphysin autoimmunity.


Subject(s)
Autoimmunity , Nerve Tissue Proteins/immunology , Paraneoplastic Syndromes/immunology , Rhabdomyolysis/immunology , Stiff-Person Syndrome/immunology , Animals , Autoantibodies/blood , Blotting, Western , Breast Neoplasms/complications , Breast Neoplasms/physiopathology , CHO Cells , Cricetinae , Female , Fluorescent Antibody Technique , Humans , Immunoglobulins/therapeutic use , Middle Aged , Muscle, Skeletal/immunology , Muscle, Skeletal/pathology , Paraneoplastic Syndromes/drug therapy , Rhabdomyolysis/complications , Rhabdomyolysis/drug therapy , Spinal Cord/pathology , Stiff-Person Syndrome/complications , Stiff-Person Syndrome/drug therapy
3.
Traffic ; 5(7): 514-28, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15180828

ABSTRACT

Amphiphysin is a protein enriched at mammalian synapses thought to function as a clathrin accessory factor in synaptic vesicle endocytosis. Here we examine the involvement of amphiphysin in synaptic vesicle recycling at the giant synapse in the lamprey. We show that amphiphysin resides in the synaptic vesicle cluster at rest and relocates to sites of endocytosis during synaptic activity. It accumulates at coated pits where its SH3 domain, but not its central clathrin/AP-2-binding (CLAP) region, is accessible for antibody binding. Microinjection of antibodies specifically directed against the CLAP region inhibited recycling of synaptic vesicles and caused accumulation of clathrin-coated intermediates with distorted morphology, including flat patches of coated presynaptic membrane. Our data provide evidence for an activity-dependent redistribution of amphiphysin in intact nerve terminals and show that amphiphysin is a component of presynaptic clathrin-coated intermediates formed during synaptic vesicle recycling.


Subject(s)
Clathrin/chemistry , Nerve Tissue Proteins/physiology , Synapses/metabolism , Synaptic Vesicles/metabolism , Amino Acid Sequence , Animals , Antibodies, Monoclonal/chemistry , Central Nervous System/metabolism , Chromatography, Affinity , Endocytosis , Glutathione Transferase/metabolism , Humans , Immunohistochemistry , Lampreys , Microscopy, Electron , Microscopy, Fluorescence , Molecular Sequence Data , Open Reading Frames , Protein Binding , Protein Structure, Tertiary , Recombinant Fusion Proteins/chemistry , Recombinant Proteins/chemistry , Sequence Homology, Amino Acid , Synapses/chemistry , Synaptic Transmission , src Homology Domains
4.
Science ; 297(5584): 1193-6, 2002 Aug 16.
Article in English | MEDLINE | ID: mdl-12183633

ABSTRACT

In striated muscle, the plasma membrane forms tubular invaginations (transverse tubules or T-tubules) that function in depolarization-contraction coupling. Caveolin-3 and amphiphysin were implicated in their biogenesis. Amphiphysin isoforms have a putative role in membrane deformation at endocytic sites. An isoform of amphiphysin 2 concentrated at T-tubules induced tubular plasma membrane invaginations when expressed in nonmuscle cells. This property required exon 10, a phosphoinositide-binding module. In developing myotubes, amphiphysin 2 and caveolin-3 segregated in tubular and vesicular portions of the T-tubule system, respectively. These findings support a role of the bilayer-deforming properties of amphiphysin at T-tubules and, more generally, a physiological role of amphiphysin in membrane deformation.


Subject(s)
Cell Membrane Structures/ultrastructure , Muscle Development , Muscle, Skeletal/ultrastructure , Nerve Tissue Proteins/metabolism , Animals , CHO Cells , Caveolin 3 , Caveolins/metabolism , Cell Differentiation , Cell Line , Cell Membrane/metabolism , Cell Membrane Structures/metabolism , Cricetinae , Dynamins , Exons , GTP Phosphohydrolases/metabolism , Liposomes/metabolism , Mice , Microscopy, Electron , Morphogenesis , Muscle, Skeletal/metabolism , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/genetics , Phosphatidylinositol 4,5-Diphosphate/metabolism , Protein Isoforms , Protein Structure, Tertiary , RNA, Small Interfering , RNA, Untranslated/metabolism , Recombinant Fusion Proteins/metabolism , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL